The case for entrepreneurship in R&D in the pharmaceutical industry.
A lack of entrepreneurial behaviour has often been highlighted as a contributor to the decline in the research and development (R&D) productivity of the pharmaceutical industry. Here, we present an assessment of entrepreneurship in the industry, based on interviews with 26 former and current leaders of R&D departments at major pharmaceutical and biotechnology companies. Factors are highlighted that could be important in promoting entrepreneurial behaviour, which might serve as a catalyst for revitalizing R&D productivity.
Douglas
Frank L
FL
Ewing Marion Kauffman Foundation, Kansas City, Missouri, USA. fdouglas@kauffman.org
Narayanan
V K
VK
Mitchell
Lesa
L
Litan
Robert E
RE
D001709:Biotechnology / Q000191:economics / Q000458:organization & administration*; D015195:Drug Design; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration*; D017598:Efficiency, Organizational; D016520:Entrepreneurship; D006801:Humans; D012106:Research / Q000191:economics / Q000458:organization & administration